| Identification | Back Directory | [Name]
Imidazo[1,2-b]pyridazine-3-carboxamide, N-[(4-fluorophenyl)methyl]-6-[(2R)-2-(3-fluorophenyl)-1-pyrrolidinyl]- | [CAS]
1365212-84-5 | [Synonyms]
TRK-IN-14
Imidazo[1,2-b]pyridazine-3-carboxamide, N-[(4-fluorophenyl)methyl]-6-[(2R)-2-(3-fluorophenyl)-1-pyrrolidinyl]- | [Molecular Formula]
C24H21F2N5O | [MOL File]
1365212-84-5.mol | [Molecular Weight]
433.45 |
| Hazard Information | Back Directory | [Uses]
TRK-IN-14 is a potent inhibitor of TRK. Protein kinases play a critical role in the control of cell growth and differentiation and are responsible for the control of a wide variety of cellular signal transduction processes. TRK-IN-14 has the potential for the research of TRK-related diseases (extracted from patent WO2012034091A1, compound X-47)[1]. | [References]
[1] Yi Fan, et al. Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors. Patent WO2012034091A1. |
|
|